Stock Analysis on Net

Becton, Dickinson & Co. (NYSE:BDX)

Common Stock Valuation Ratios (Price Multiples)

Microsoft Excel LibreOffice Calc

Current Valuation Ratios

Becton, Dickinson & Co., current price multiples

Microsoft Excel LibreOffice Calc
Becton, Dickinson & Co. Abbott Laboratories Anthem Inc. Bristol-Myers Squibb Co. CVS Health Corp. Danaher Corp. Edwards Lifesciences Corp. HCA Healthcare Inc. Intuitive Surgical Inc. Medtronic PLC Stryker Corp. UnitedHealth Group Inc. Health Care Equipment & Services Health Care
Selected Financial Data
Current share price (P) $264.63
No. shares of common stock outstanding 284,023,582
Growth rate (g) 1.53%
 
Earnings per share (EPS) $7.05
Next year expected EPS $7.16
Operating profit per share $9.85
Sales per share $71.29
Book value per share (BVPS) $83.36
Valuation Ratios (Price Multiples)
Price to earnings (P/E) 37.54 49.50 23.44 18.67 57.09 85.42 19.71 90.78 39.37 60.08 28.20 46.06 38.88
Price to next year expected earnings 36.98 51.43 21.17 17.24 52.73 70.22 2.74 79.44 38.40 54.63 24.32 42.85 36.01
Price-earnings-growth (PEG) 24.57 2.18 2.24 6.89 3.95 0.03 6.36 15.56 6.01 1.77 6.14 4.87
Price to operating profit (P/OP) 26.85 41.54 17.87 9.64 47.37 78.35 10.20 91.72 31.66 43.22 19.39 29.68 27.69
Price to sales (P/S) 3.71 6.43 0.89 3.32 0.50 8.99 16.03 1.44 22.09 4.71 6.69 1.70 2.07 3.21
Price to book value (P/BV) 3.17 6.79 3.23 3.73 1.93 5.04 15.38 129.37 9.89 2.76 7.34 6.63 4.71 6.12

Based on: 10-K (reporting date: 2021-09-30).

If the company price multiple is lower then the price multiple of benchmark then company stock is relatively undervalued.
Otherwise, if the company price multiple is higher then the price multiple of benchmark then company stock is relatively overvalued.


Historical Valuation Ratios (Summary)

Becton, Dickinson & Co., historical price multiples

Microsoft Excel LibreOffice Calc
Sep 30, 2021 Sep 30, 2020 Sep 30, 2019 Sep 30, 2018 Sep 30, 2017 Sep 30, 2016
Price to earnings (P/E) 34.68 86.01 65.09 408.36 49.63 36.65
Price to operating profit (P/OP) 24.81 44.46 40.02 43.37 34.59 25.02
Price to sales (P/S) 3.43 3.85 4.07 4.06 4.23 2.87
Price to book value (P/BV) 2.93 2.78 3.34 3.09 3.95 4.69

Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).

Valuation ratio Description The company
P/E ratio The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings. Becton, Dickinson & Co. P/E ratio increased from 2019 to 2020 but then decreased significantly from 2020 to 2021.
P/OP ratio Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit. Becton, Dickinson & Co. P/OP ratio increased from 2019 to 2020 but then decreased significantly from 2020 to 2021.
P/S ratio An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative. Becton, Dickinson & Co. P/S ratio decreased from 2019 to 2020 and from 2020 to 2021.
P/BV ratio The P/BV ratio is interpreted as an indicator of market judgment about the relationship between a company required rate of return and its actual rate of return. Becton, Dickinson & Co. P/BV ratio decreased from 2019 to 2020 but then slightly increased from 2020 to 2021.

Price to Earnings (P/E)

Becton, Dickinson & Co., historical P/E calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Sep 30, 2021 Sep 30, 2020 Sep 30, 2019 Sep 30, 2018 Sep 30, 2017 Sep 30, 2016
No. shares of common stock outstanding1 284,023,582 290,031,363 270,459,892 268,257,940 227,978,328 212,319,588
Selected Financial Data (US$)
Net income applicable to common shareholders (in millions) 2,002  767  1,082  159  1,030  976 
Earnings per share (EPS)2 7.05 2.64 4.00 0.59 4.52 4.60
Share price1, 3 244.46 227.47 260.40 242.04 224.23 168.48
Valuation Ratio
P/E ratio4 34.68 86.01 65.09 408.36 49.63 36.65
Benchmarks
P/E Ratio, Competitors5
Abbott Laboratories 48.49 41.83 56.47 220.29 55.16
Anthem Inc. 15.87 15.96 21.45 15.44 17.48
Bristol-Myers Squibb Co. 41.99 16.81 103.55 20.56
CVS Health Corp. 12.88 14.15 10.69 14.91
Danaher Corp. 44.49 38.34 29.77 27.25 23.02
Edwards Lifesciences Corp. 66.48 46.05 51.14 48.16 33.48
HCA Healthcare Inc. 16.06 14.30 12.84 15.92 11.00
Intuitive Surgical Inc. 87.47 48.72 53.03 70.95 37.16
Medtronic PLC 46.56 26.30 28.78 37.80 29.96 33.17
Stryker Corp. 57.72 39.24 18.96 54.36 27.92
UnitedHealth Group Inc. 20.54 20.48 21.09 20.77 21.73
P/E Ratio, Sector
Health Care Equipment & Services 38.06 26.82 29.27 27.92 23.23
P/E Ratio, Industry
Health Care 32.78 22.47 25.66 30.91 21.33

Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).

1 Data adjusted for splits and stock dividends.

2 2021 Calculation
EPS = Net income applicable to common shareholders ÷ No. shares of common stock outstanding
= 2,002,000,000 ÷ 284,023,582 = 7.05

3 Closing price as at the filing date of Becton, Dickinson & Co. Annual Report.

4 2021 Calculation
P/E ratio = Share price ÷ EPS
= 244.46 ÷ 7.05 = 34.68

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/E ratio The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings. Becton, Dickinson & Co. P/E ratio increased from 2019 to 2020 but then decreased significantly from 2020 to 2021.

Price to Operating Profit (P/OP)

Becton, Dickinson & Co., historical P/OP calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Sep 30, 2021 Sep 30, 2020 Sep 30, 2019 Sep 30, 2018 Sep 30, 2017 Sep 30, 2016
No. shares of common stock outstanding1 284,023,582 290,031,363 270,459,892 268,257,940 227,978,328 212,319,588
Selected Financial Data (US$)
Operating income (in millions) 2,799  1,484  1,760  1,497  1,478  1,430 
Operating profit per share2 9.85 5.12 6.51 5.58 6.48 6.74
Share price1, 3 244.46 227.47 260.40 242.04 224.23 168.48
Valuation Ratio
P/OP ratio4 24.81 44.46 40.02 43.37 34.59 25.02
Benchmarks
P/OP Ratio, Competitors5
Abbott Laboratories 40.69 34.03 36.64 60.88 24.25
Anthem Inc. 12.10 13.55 15.87 14.81 9.36
Bristol-Myers Squibb Co. 24.42 16.16 28.87 19.79
CVS Health Corp. 6.65 7.83 18.65 7.44 7.65
Danaher Corp. 36.91 34.47 23.18 22.48 21.37
Edwards Lifesciences Corp. 60.98 42.04 49.37 25.66 25.38
HCA Healthcare Inc. 8.31 6.93 6.88 5.82 5.11
Intuitive Surgical Inc. 88.37 48.89 49.87 44.40 28.93
Medtronic PLC 37.44 26.29 21.26 17.64 22.64 22.18
Stryker Corp. 41.52 30.13 26.55 24.21 21.23
UnitedHealth Group Inc. 14.12 14.40 14.58 14.42 11.79
P/OP Ratio, Sector
Health Care Equipment & Services 24.53 18.40 18.84 17.72 14.11
P/OP Ratio, Industry
Health Care 23.35 18.19 18.66 17.23 14.59

Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).

1 Data adjusted for splits and stock dividends.

2 2021 Calculation
Operating profit per share = Operating income ÷ No. shares of common stock outstanding
= 2,799,000,000 ÷ 284,023,582 = 9.85

3 Closing price as at the filing date of Becton, Dickinson & Co. Annual Report.

4 2021 Calculation
P/OP ratio = Share price ÷ Operating profit per share
= 244.46 ÷ 9.85 = 24.81

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/OP ratio Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit. Becton, Dickinson & Co. P/OP ratio increased from 2019 to 2020 but then decreased significantly from 2020 to 2021.

Price to Sales (P/S)

Becton, Dickinson & Co., historical P/S calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Sep 30, 2021 Sep 30, 2020 Sep 30, 2019 Sep 30, 2018 Sep 30, 2017 Sep 30, 2016
No. shares of common stock outstanding1 284,023,582 290,031,363 270,459,892 268,257,940 227,978,328 212,319,588
Selected Financial Data (US$)
Revenues (in millions) 20,248  17,117  17,290  15,983  12,093  12,483 
Sales per share2 71.29 59.02 63.93 59.58 53.04 58.79
Share price1, 3 244.46 227.47 260.40 242.04 224.23 168.48
Valuation Ratio
P/S ratio4 3.43 3.85 4.07 4.06 4.23 2.87
Benchmarks
P/S Ratio, Competitors5
Abbott Laboratories 6.30 4.83 4.37 3.84 3.70
Anthem Inc. 0.60 0.74 0.88 0.67 0.51
Bristol-Myers Squibb Co. 3.16 5.52 3.67 5.02 4.72
CVS Health Corp. 0.35 0.37 0.39 0.38 0.45
Danaher Corp. 7.01 6.29 3.97 3.70 3.48
Edwards Lifesciences Corp. 12.48 11.09 9.92 8.18 6.43
HCA Healthcare Inc. 1.17 0.98 1.04 0.81 0.77
Intuitive Surgical Inc. 21.29 15.01 16.06 14.97 10.11
Medtronic PLC 5.57 4.36 4.36 3.92 4.06 4.07
Stryker Corp. 6.43 5.49 4.95 4.46 4.06
UnitedHealth Group Inc. 1.24 1.18 1.12 1.10 0.83
P/S Ratio, Sector
Health Care Equipment & Services 1.71 1.65 1.58 1.50 1.29
P/S Ratio, Industry
Health Care 2.71 2.54 2.52 2.47 2.26

Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).

1 Data adjusted for splits and stock dividends.

2 2021 Calculation
Sales per share = Revenues ÷ No. shares of common stock outstanding
= 20,248,000,000 ÷ 284,023,582 = 71.29

3 Closing price as at the filing date of Becton, Dickinson & Co. Annual Report.

4 2021 Calculation
P/S ratio = Share price ÷ Sales per share
= 244.46 ÷ 71.29 = 3.43

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/S ratio An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative. Becton, Dickinson & Co. P/S ratio decreased from 2019 to 2020 and from 2020 to 2021.

Price to Book Value (P/BV)

Becton, Dickinson & Co., historical P/BV calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Sep 30, 2021 Sep 30, 2020 Sep 30, 2019 Sep 30, 2018 Sep 30, 2017 Sep 30, 2016
No. shares of common stock outstanding1 284,023,582 290,031,363 270,459,892 268,257,940 227,978,328 212,319,588
Selected Financial Data (US$)
Shareholders’ equity (in millions) 23,677  23,765  21,081  20,994  12,948  7,633 
Book value per share (BVPS)2 83.36 81.94 77.95 78.26 56.79 35.95
Share price1, 3 244.46 227.47 260.40 242.04 224.23 168.48
Valuation Ratio
P/BV ratio4 2.93 2.78 3.34 3.09 3.95 4.69
Benchmarks
P/BV Ratio, Competitors5
Abbott Laboratories 6.65 4.96 4.38 3.40 3.76
Anthem Inc. 2.19 2.42 2.82 2.24 1.72
Bristol-Myers Squibb Co. 3.55 2.80 5.89 8.88 5.66
CVS Health Corp. 1.33 1.47 1.29 1.88 2.15
Danaher Corp. 3.93 3.72 2.80 2.58 2.56
Edwards Lifesciences Corp. 11.97 11.62 11.76 9.51 7.28
HCA Healthcare Inc. 105.40
Intuitive Surgical Inc. 9.53 8.13 8.96 9.91 4.73
Medtronic PLC 3.26 2.48 2.66 2.31 2.40 2.25
Stryker Corp. 7.05 6.38 5.74 5.56 4.82
UnitedHealth Group Inc. 4.83 4.92 4.89 4.59 3.98
P/BV Ratio, Sector
Health Care Equipment & Services 3.89 3.66 3.67 3.78 3.39
P/BV Ratio, Industry
Health Care 5.16 4.90 4.86 4.52 4.09

Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).

1 Data adjusted for splits and stock dividends.

2 2021 Calculation
BVPS = Shareholders’ equity ÷ No. shares of common stock outstanding
= 23,677,000,000 ÷ 284,023,582 = 83.36

3 Closing price as at the filing date of Becton, Dickinson & Co. Annual Report.

4 2021 Calculation
P/BV ratio = Share price ÷ BVPS
= 244.46 ÷ 83.36 = 2.93

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/BV ratio The P/BV ratio is interpreted as an indicator of market judgment about the relationship between a company required rate of return and its actual rate of return. Becton, Dickinson & Co. P/BV ratio decreased from 2019 to 2020 but then slightly increased from 2020 to 2021.